Skip to main content

ORIX Corporation

corporate_fare Company Profile

ORIX Corporation

IX·NYSE·Finance·CIK 0001070304

ORIX CORP is a financial services group that focuses on its human capital and compensation policies. The company aims to provide an attractive workplace where employees are motivated and fulfilled, and their contributions are recognized through an appropriately designed compensation system. ORIX's compensation system is based on the principle of "evaluation and treatment aligned with job responsibilities and performance." Fixed compensation is determined by an employee's roles and job responsibilities, while variable compensation (bonuses) is based on performance outcomes. This evaluation program applies to all employees, and bonuses reflect both individual performance and overall company performance. ORIX has also implemented an incentive plan using restricted shares for certain manager- and executive-level employees. This plan aims to increase their participation in management and encourage actions that contribute to the medium- to long-term and sustainable improvement of corporate value. The company's fair treatment policy includes individual goal setting and evaluation. This consists of a "Goal Contribution Evaluation," which assesses results against goals set with supervisors, and a "Role Behavior Evaluation," which assesses adherence to expected behavioral guidelines for each job category and grade. The "Goal Contribution Evaluation" impacts bonuses, while the "Role Behavior Evaluation" influences salary increases and promotions. ORIX emphasizes regular dialogue between supervisors and employees to ensure fairness in the evaluation program, including clarifying roles, setting goals, conducting progress reviews, and providing feedback on evaluation results.

ORIX Corporation (NYSE:IX) is a publicly traded company in the Finance sector. Wiseek has independently scored 18 items for IX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 18 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for IX spans 6-K, 20-F.

Recent high-impact activity:

  • ORIX H1 Net Income Jumps 216% to ¥856.2B on Kioxia-Linked Equity Gain
  • ORIX Subsidiary Launches JPY 1,490/Share Tender Offer for IBC in JPY 6.5 Billion Take-Private
  • ORIX H1 Net Income Jumps 216% to ¥856.2B on Kioxia Gain; Interim Dividend Raised to ¥113.56
  • ORIX Q1 Net Income Surges 162% to ¥280.8B; Full-Year Guidance Raised to ¥530B
  • ORIX Finalizes Network Connex Divestment Date, Updates Corporate Governance

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
¥3.33T JPY
Net Income
¥447.26B JPY
Op. Cash Flow
¥1.37T JPY
Operating Income
¥456.25B JPY
Cash & Equivalents
¥1.33T JPY
Total Debt
¥6.54T JPY
Debt / Equity
1.46×
Net Margin
13.4%
Shares Outstanding
1.12B sh
Source: 20-F · filed 2026-06-22 · accession 0001193125-26-276640

Short Interest & Short Volume

4.71 days to cover

FINRA reported short interest of 862,497 shares in IX as of the October 30, 2026 settlement, a 0.1% increase from the prior period — about 4.7 days to cover at its recent average daily volume. On November 20, 2026, 44.5% of IX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)862,497 shares as of October 30, 2026
Change vs prior period▲ 0.1%
Days to cover4.71 at avg daily volume of 183,055
Daily short volume (FINRA facilities)44.5% of 169,749 shares on November 20, 2026
5-day average short volume36.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

IX files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with I →
$32.01
52-week range · as of 2026-11-12 $25.26 – $42.39
Market cap
$33.92B
Volume
307.3K (1.1× avg)
3-mo avg 284K
Live data · 2026-11-22 09:48 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed IX - Latest Insights

IX
Nov 12, 2026, 7:22 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $33.85
Real-time Price: $32.01 info
Change: -$1.84 (-5%) info
Market Cap: $33.92B info
IX
Nov 12, 2026, 7:14 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $33.85
Real-time Price: $32.01 info
Change: -$1.84 (-5%) info
Market Cap: $33.92B info
IX
Nov 09, 2026, 6:38 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $34.58
Real-time Price: $32.01 info
Change: -$2.57 (-7%) info
Market Cap: $33.92B info
IX
Aug 06, 2026, 6:05 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $41.31
Real-time Price: $32.01 info
Change: -$9.30 (-23%) info
Market Cap: $33.92B info
IX
Jun 30, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $38.01
Real-time Price: $32.01 info
Change: -$6.00 (-16%) info
Market Cap: $33.92B info
IX
Jun 22, 2026, 6:25 AM EDT
Filing Type: 20-F
Importance Score:
8
Price at Filing: $39.87
Real-time Price: $32.01 info
Change: -$7.86 (-20%) info
Market Cap: $33.92B info
IX
May 26, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $38.50
Real-time Price: $32.01 info
Change: -$6.49 (-17%) info
Market Cap: $33.92B info
IX
May 21, 2026, 7:39 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $39.87
Real-time Price: $32.01 info
Change: -$7.86 (-20%) info
Market Cap: $33.92B info
IX
May 15, 2026, 9:23 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $36.61
Real-time Price: $32.01 info
Change: -$4.60 (-13%) info
Market Cap: $33.92B info
IX
May 11, 2026, 11:08 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $36.58
Real-time Price: $32.01 info
Change: -$4.57 (-12%) info
Market Cap: $33.92B info
IX
Apr 27, 2026, 6:04 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $31.11
Real-time Price: $32.01 info
Change: +$0.900 (+3%) info
Market Cap: $33.92B info
IX
Apr 14, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $31.04
Real-time Price: $32.01 info
Change: +$0.970 (+3%) info
Market Cap: $33.92B info
IX
Mar 27, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $29.63
Real-time Price: $32.01 info
Change: +$2.38 (+8%) info
Market Cap: $33.92B info
IX
Mar 04, 2026, 6:01 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $31.85
Real-time Price: $32.01 info
Change: +$0.160 (+0.50%) info
Market Cap: $33.92B info
IX
Mar 02, 2026, 6:01 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $34.44
Real-time Price: $32.01 info
Change: -$2.43 (-7%) info
Market Cap: $33.92B info
IX
Feb 09, 2026, 6:01 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $32.30
Real-time Price: $32.01 info
Change: -$0.290 (-0.90%) info
Market Cap: $33.92B info
IX
Feb 04, 2026, 6:03 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $30.60
Real-time Price: $32.01 info
Change: +$1.41 (+5%) info
Market Cap: $33.92B info
IX
Jan 07, 2026, 6:02 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $30.01
Real-time Price: $32.01 info
Change: +$2.00 (+7%) info
Market Cap: $33.92B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets